QPlus Pediatric Reference Interval

NCT05645133 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2023-06-15

No results posted yet for this study

Summary

Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.

Conditions

  • Pediatric ALL
  • Healthy

Interventions

DEVICE

Diagnostic Test

Diagnostic device to monitor coagulation properties of a whole blood sample at the point of care

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Principal Investigators

  • Christopher Tirotta, MD · Nicklaus Childrens

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2023-06-01
Completion
2023-06-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05645133 on ClinicalTrials.gov